Literature DB >> 26034183

Guidance on switching away from Piportil Depot® (pipotiazine palmitate) injection.

Peter Haddad1, Mark Taylor1, Maxine X Patel1, David Taylor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26034183     DOI： 10.1192/bjp.206.6.521

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  2 in total

1.  Switching away from pipotiazine palmitate: a naturalistic study.

Authors:  Feras Ali Mustafa
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-13

2.  Clinical outcomes following switching antipsychotic treatment due to market withdrawal: a retrospective naturalistic cohort study of pipotiazine palmitate injection (Piportil Depot) discontinuation, subsequent acute care use and effectiveness of medication to which patients switched.

Authors:  Rollo J G Sheldon; Marco Pereira; George Aldersley; Tim Sales; Jed Hewitt; Ray Lyon; Richard Whale
Journal:  Ther Adv Psychopharmacol       Date:  2022-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.